Lista de obras - Anja H Simonsen - Dominio Público Uruguay

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

artículo científico publicado en 2017

A disease state fingerprint for evaluation of Alzheimer's disease

artículo científico publicado en 2011

A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia

artículo científico publicado en 2007

Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods

artículo científico publicado en 2007

Application of the PredictAD decision support tool to a Danish cohort of patients with Alzheimer's disease and other dementias

artículo científico publicado en 2013

Application of the PredictAD software tool to predict progression in patients with mild cognitive impairment

artículo científico publicado en 2012

Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting

artículo científico publicado en 2016

Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives

artículo científico publicado en 2015

Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review.

artículo científico publicado en 2019

Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic review

scholarly article by Ulla Knorr et al published July 2018 in European Neuropsychopharmacology

CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers

artículo científico publicado en 2017

Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease

artículo científico publicado en 2016

Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia

artículo científico publicado en 2015

Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review

scientific article published on 01 January 2019

Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease

artículo científico publicado en 2020

Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias

scientific article published on 06 April 2020

Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study

artículo científico publicado en 2019

Characterization and stability of transthyretin isoforms in cerebrospinal fluid examined by immunoprecipitation and high-resolution mass spectrometry of intact protein.

artículo científico publicado en 2012

Chasing the Effects of Pre-Analytical Confounders - A Multicenter Study on CSF-AD Biomarkers

artículo científico publicado en 2015

Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis

artículo científico publicado en 2010

Cystatin C in cerebrospinal fluid and multiple sclerosis

artículo científico publicado en 2007

Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer's disease and mild cognitive impairment

artículo científico publicado en 2014

Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?

artículo científico publicado en 2015

Effect of Ageing on the Passive and Active Tension and Pharmacodynamic Characteristics of Rat Coronary Arteries: Age-Dependent Increase in Sensitivity to 5-HT and K+

artículo científico publicado en 2012

Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease

artículo científico publicado en 2017

Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma

scientific article published on 11 April 2019

Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.

artículo científico publicado en 2005

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

artículo científico publicado en 2007

Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study

artículo científico publicado en 2019

Inflammatory markers of CHMP2B-mediated frontotemporal dementia

artículo científico publicado en 2018

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

scientific article published on 06 April 2019

Measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine and 8-oxo-7,8-dihydro-guanosine in cerebrospinal fluid by ultra performance liquid chromatography-tandem mass spectrometry

artículo científico publicado en 2017

Neprilysin-like activity correlates with CSF-Tau and phospho-tau in patients with Alzheimer's disease

artículo científico publicado en 2013

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment

artículo científico publicado en 2007

Patients with Alzheimer's disease who carry the ε4 allele benefit more from physical exercise

artículo científico publicado en 2019

Physical Exercise May Increase Plasma Concentration of High-Density Lipoprotein-Cholesterol in Patients With Alzheimer's Disease

artículo científico publicado en 2020

Pre-analytical factors influencing the stability of cerebrospinal fluid proteins

artículo científico publicado en 2013

Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design

artículo científico publicado en 2013

Progressive DNA and RNA damage from oxidation after aneurysmal subarachnoid haemorrhage in humans

artículo científico publicado en 2017

Protein markers for the differential diagnosis of vascular dementia and Alzheimer's disease

artículo científico publicado en 2012

Protein profiling of cerebrospinal fluid.

artículo científico publicado en 2012

Proteomic investigations of the ventriculo-lumbar gradient in human CSF.

artículo científico publicado en 2010

Quantitative Electroencephalography Analyzed by Statistical Pattern Recognition as a Diagnostic and Prognostic Tool in Mild Cognitive Impairment: Results from a Nordic Multicenter Cohort Study

scholarly article published in Dementia and geriatric cognitive disorders extra

Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers

article

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

artículo científico publicado en 2016

Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

artículo científico publicado en 2016

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

artículo científico publicado en 2012

Sample handling for mass spectrometric proteomic investigations of human urine

artículo científico publicado en 2008

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

artículo científico publicado en 2015

The Diagnostic and Prognostic Value of a Dual-Tasking Paradigm in a Memory Clinic

artículo científico publicado en 2017

The PredictAD project: development of novel biomarkers and analysis software for early diagnosis of the Alzheimer's disease

artículo científico publicado en 2013

The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review

artículo científico

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature

artículo científico

Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology

artículo científico publicado en 2009

Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease.

artículo científico publicado en 2015

YKL-40 in cerebrospinal fluid in Huntington's disease--a role in pathology or a nonspecific response to inflammation?

artículo científico publicado en 2014

Lista de obras de Anja H Simonsen

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

A disease state fingerprint for evaluation of Alzheimer's disease

A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia

Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods

Application of the PredictAD decision support tool to a Danish cohort of patients with Alzheimer's disease and other dementias

Application of the PredictAD software tool to predict progression in patients with mild cognitive impairment

Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting

Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives

Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review.

Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic review

CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers

Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease

Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia

Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review

Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease

Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias

Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study

Characterization and stability of transthyretin isoforms in cerebrospinal fluid examined by immunoprecipitation and high-resolution mass spectrometry of intact protein.

Chasing the Effects of Pre-Analytical Confounders - A Multicenter Study on CSF-AD Biomarkers

Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis

Cystatin C in cerebrospinal fluid and multiple sclerosis

Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer's disease and mild cognitive impairment

Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?

Effect of Ageing on the Passive and Active Tension and Pharmacodynamic Characteristics of Rat Coronary Arteries: Age-Dependent Increase in Sensitivity to 5-HT and K+

Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease

Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma

Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study

Inflammatory markers of CHMP2B-mediated frontotemporal dementia

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

Measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine and 8-oxo-7,8-dihydro-guanosine in cerebrospinal fluid by ultra performance liquid chromatography-tandem mass spectrometry

Neprilysin-like activity correlates with CSF-Tau and phospho-tau in patients with Alzheimer's disease

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment

Patients with Alzheimer's disease who carry the ε4 allele benefit more from physical exercise

Physical Exercise May Increase Plasma Concentration of High-Density Lipoprotein-Cholesterol in Patients With Alzheimer's Disease

Pre-analytical factors influencing the stability of cerebrospinal fluid proteins

Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design

Progressive DNA and RNA damage from oxidation after aneurysmal subarachnoid haemorrhage in humans

Protein markers for the differential diagnosis of vascular dementia and Alzheimer's disease

Protein profiling of cerebrospinal fluid.

Proteomic investigations of the ventriculo-lumbar gradient in human CSF.

Quantitative Electroencephalography Analyzed by Statistical Pattern Recognition as a Diagnostic and Prognostic Tool in Mild Cognitive Impairment: Results from a Nordic Multicenter Cohort Study

Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

Sample handling for mass spectrometric proteomic investigations of human urine

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

The Diagnostic and Prognostic Value of a Dual-Tasking Paradigm in a Memory Clinic

The PredictAD project: development of novel biomarkers and analysis software for early diagnosis of the Alzheimer's disease

The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature

Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology

Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease.

YKL-40 in cerebrospinal fluid in Huntington's disease--a role in pathology or a nonspecific response to inflammation?